Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20181222042074N1Phase 3Completed
Phase 3, open-label trial of autologous bone-marrow mesenchymal stem cells in scaphoid nonunion (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: The rate of bone formation and The rate of callus tissue formation. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20181222042074N1.